autmation

Sales & Marketing

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs).

News

Novartis has agreed to buy a PI3Kα-targeting drug for breast cancer from Synnovation, a potential successor to its Piqray brand, for $2bn upfront.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.